[ad_1]
FILE – This photo taken on May 8, 2007 shows Purdue Pharma's offices in Stamford, Connecticut On Wednesday, September 5, 2018, the company, whose prescription opioid marketing practices are accused of triggering an overdose crisis and addiction, to fund an effort to create an antidote for overdoses at a lower cost. (Douglas Healey, File / Associated Press)
The latest on Purdue Pharma funding to help develop a less expensive overdose antidote (all local time):
2:45 p.m.
A local government lawyer suing the opioid industry is questioning the motives of a major producer of prescription pain medications to get an antidote for less expensive overdoses.
According to Paul Hanly, Purdue Pharma's $ 3.4 million is "a strategic step" for a judge who oversees over 1,000 lawsuits against the pharmaceutical industry. At the same time, he said, it is advantageous to have a less expensive version of the nasal spray naloxone (nuh-LAHX'-ohn).
The company that makes OxyContin announced Wednesday the grant to Harm Reduction Therapeutics, a nonprofit organization based in Pittsburgh. Purdue says that it advances public safety.
The antidote is widely used but can be expensive for governments struggling against the effects of an opioid overdose at the national level.
___
24:15
A company whose prescription opioid marketing practices are accused of triggering an overdose and addiction crisis nationally says it is helping to fund an effort to create an antidote for overdoses at a lower cost.
The manufacturer of OxyContin Purdue Pharma announced Wednesday that it would donate a $ 3.4 million grant to Harm Reduction Therapeutics, a nonprofit organization based in Pittsburgh, to help it develop a low-cost nasal spray. in naloxone (nuh-LAHX'-ohn).
First responders, drug users, and others began to wear naloxone to reverse overdoses. But the price of drugs has been a problem for state and local governments.
Harm Reduction Therapeutics says it's trying to put its release on the market within two years.
Purdue's announcement in Stamford, Connecticut, a few days after the number of lawsuits filed against the pharmaceutical industry under the supervision of a federal judge, exceeded 1,000.
Copyright 2018 The Associated Press. All rights reserved. This material may not be published, disseminated, rewritten or redistributed.
[ad_2]
Source link
